Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells

The potent and selective proteasome inhibitor bortezomib has shown remarkable antitumor activity and is now entering clinical trials for several cancers. However, the molecular mechanisms by which bortezomib induces cytotoxicity in ovarian cancer cells still remain unclear. In this study, we show th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kao, C, Chao, A, Tsai, C L, Lin, C Y, Chuang, W C, Chen, H W, Yen, T C, Wang, T H, Lai, C H, Wang, H S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3734825/
https://ncbi.nlm.nih.gov/pubmed/23449448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2013.38
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars